J Acar

Information about J Acar

Published on March 14, 2008

Author: Mahugani

Source: authorstream.com

Content

Guidance on antimicrobials and risk assessment: The OIE perspective:  Guidance on antimicrobials and risk assessment: The OIE perspective Jacques Acar M.D Emeritus Professor of Microbiology Slide2:  Since the Swann report 1969… The contribution of the use of antibiotics in animals to resistant bacteria in humans, was debated 1987: Vancomycin resistance in human isolates of Enterococci (after more than 20 years of use) 1993: Animal isolates resistant to avoparcin 1997: Ban of avoparcin animal use (EU) 1997–2004: Experiences of restriction of antibiotic use in animals; expert consultations; guidelines, codes of practice: national and international organisations Global ‘Authority’ Reports/Recommendations (few examples):  Global ‘Authority’ Reports/Recommendations (few examples) OIE (AR recommendations) FAO/Codex WHO (Berlin, FQ, Global Principles of Containment, Use Monitoring) Europe (CVMP, EU SSC, UK CMSF, UK H. Lords, Microbial Threat, etc.) Australia (JETACAR) US (NRC, CDC, CVM, GAO, IOM, etc.) Canada (Adv. Com. Report, CCAR) Japan Slide4:  World Organisation for Animal Health created in 1924 in Paris Americas: 29 – Africa: 50 – Europe: 49 – Middle East: 13 – Asia: 26 OIE 167 Member Countries Objectives:  Objectives To ensure transparency in the global animal disease and zoonosis situation To collect, analyse and disseminate scientific veterinary information Within its mandate under the WTO SPS Agreement, to safeguard world trade by publishing health standards for international trade in animals and animal products To provide a better guarantee of the safety of food of animal origin and to promote animal welfare through a science-based approach To provide expertise and encourage international solidarity in the control of animal diseases . To improve the legal framework and resources of national Veterinary Services Early investigation in Member Countries:  Early investigation in Member Countries Evaluation of veterinary services surveillance and monitoring Establish a baseline of information on animal health necessary for a science-based approach to measure the risk of antimicrobial resistant zoonotic bacteria to human health (monitoring of quantities of antibiotics used in animals, surveillance programmes for antimicrobial resistance in food animals, guidelines on prudent use of antimicrobials) Develop risk analysis methodology for adressing the problem of the impact on humans and animals of antimicrobial resistant bacteria caused by the use of antimicrobials in food animals OIE Approach:  OIE Approach Terrestrial Animal Health Code 2004 Guidelines for the harmonisation of antimicrobial resistance surveillance and monitoring programmes Guidelines for the monitoring of the quantities of antimicrobials used in animal husbandry Guidelines for the responsible and prudent use of antimicrobial agents in veterinary medicine Objectives of antimicrobial resistance surveillance and monitoring programmes:  Follow trends in antimicrobial resistance in bacteria Integration to human surveillance date Help detection of emergence of new antimicrobial resistance (new antibiotic – new mechanism) Provide a basis for policy recommendations for animal and public health Provide information for prudent use recommendations and better efficacy of prescription Provide data for conducting risk analysis Objectives of antimicrobial resistance surveillance and monitoring programmes Objectives of monitoring the quantities of antimicrobial used in animal husbandry:  Objectives of monitoring the quantities of antimicrobial used in animal husbandry Quantitative information on usage patterns, including potency and type of use. These data can be used for: Interpreting surveillance data on resistance Targeted response to problems of antimicrobial resistance Evaluating the effectiveness of prudent use guidelines Conducting Risk Analysis and planning Application of risk analysis process (Covello and Merkhofer system) to antimicrobial resistance – Code 2005:  Hazard Identification Risk Assessment Risk Management Risk Communication Application of risk analysis process (Covello and Merkhofer system) to antimicrobial resistance – Code 2005 Hazard identification:  Hazard identification The process of identifying the determinant that emerges as a result of the use of a specific antimicrobial in animals: the resistance determinant may be or in a specific zoonotic bacteria, or may be passed from one species of bacteria to another The hazard might produce adverse consequences through any scenario that could expose HUMANS, or ANIMALS, to the resistant pathogens Analysis of risks from antimicrobial resistant bacteria from animal origin should be applied ::  Analysis of risks from antimicrobial resistant bacteria from animal origin should be applied : To human health As well to animal health The Risk Assessment:  The Risk Assessment Release assessment: describes and quantifies the process linking the use of a specific antimicrobial in animals and the direct or indirect emergence of the resistant pathogen (Bacterial species; animal species; genetic mechanism of the resistance; dosage and administration of a particular antibiotic) Exposure assessment: describes the pathways by which the resistant bacteria colonise/infect a human population or an animal population (cycling of resistant bacteria; microbial load…) The Risk Assessment (2):  The Risk Assessment (2) Consequence assessment: adverse health and/or environmental consequences (wide range incompletely explored; loss of efficacy of antimicrobials; number of ill people; severity of disease; economic costs) Risk estimation: integrate the results of the previous steps (scale consequences to allow weighted summation) Risk Management:  Risk Management Risk management policy – a framework for monitoring, measuring, assessing and managing the risk involved in the use of antimicrobials in food-producing animals. The risk management policy should be established at the beginning of the process of risk analysis. Risk management components: Risk evaluation Options/evaluation Process of implementation Monitoring and review programme When data are insufficient or inadequate to answer the risk question, the risk decision is temporary Risk Communication:  Risk Communication Interactive exchange of information on risk among risk assessors, risk managers, and other interested parties (stakeholders) Programme to establish EARLY from the intention to perform a risk analysis to the implementation of the risk management decisions Risk Communication (2):  Risk Communication (2) Promote awareness and understanding of the specific issues Promote consistency and transparency in implementing risk management decisions Provide sound basis for understanding the risk management decisions implemented Improve effectiveness/efficiency of the process Strengthen working relationships among participants Promote appropriate involvement of stakeholders Exchange information concerning the risk at hand OIE Recommendations:  OIE Recommendations Risk assessment should be objective and defensible Process should be transparent and consistent Risk management and risk assessment functions should be separate to ensure independence of decision making and evaluation of the risk Risk management should be conducted using a policy framework that sets the domain of the regulator and range of risk reduction actions to consider OIE Recommendations (2):  OIE Recommendations (2) Risk assessment should be based on sound science and conducted according to a strategy developed with managers and assessors Qualitative risk assessment should be undertaken and provide information on whether full quantitative or semi-quantitative risk assessment is feasible or necessary Help developing countries develop/access skills required for risk assessment – Harmonisation effort Communication among managers, assessors and stakeholders is essential Slide20:  Developping science, fairly new Different methods: farm to fork – top-down approach Different models to describe bio-pathways: differents variables: antibiotic to resistance marker (bacteria) resistant strains from animals to human colonisation and infection Broad range of human health impacts and animal health impact Qualitative, semiquantitative, quantitative studies Risk analysis applied to antimicrobial resistant bacteria Slide21:  CVM FDA guidance (based on OIE guidelines) – possible use of qualitative approach and possible development In USA, Europe and Australia: 2 qualitative studies 3 quantitative studies 2 semiquantative studies Identification of problems, or special factors to be considered:  Identification of problems, or special factors to be considered Resistance determinant – Microorganism: clonal spread vs horizontal and clonal spread Microbial population Density ; Load Mixture of resistant and susceptible subpopulations Bacterial variability (serotypes, phenotypes…) affect uncertainty (duration of the study) Identification of problems, or special factors to be considered (contd):  Identification of problems, or special factors to be considered (contd) Complexity of resistance mechanisms: More than one for an antibiotic Cross resistance Co-resistance Linkage of resistance determinant to fitness, to virulence… Relation between commensals and pathogens Complex pathways (methods for risk attribution) Environmental factors Transmission (animals, farmers, humans, environmental) in both direction Food processing; preparation… Other sources of contamination than food Other origin of contamination (travel) Slide24:  Choose the most appropriate type of study according available data (identification of key data needs for further development. Methods and models will evolve as more adequate information will become available Importance to recognize essential antibiotics for humans as well for animals – Threshold of resistance (alert) Optimize the use of existing surveillance systems (bacteria; antimicrobial resistance; infections; outcome of treatment…) in humans and animals Give chance for risk assessors, microbiologists and risk managers to work more closely together Slide25:  Not as Mark Twain once said: “Researchers have already cast much darkness on this subject. If they continue their investigations we shall soon know nothing at all”.

Related presentations


Other presentations created by Mahugani

Exploring the Deep Web
12. 03. 2008
0 views

Exploring the Deep Web

Moving Mountains
02. 10. 2007
0 views

Moving Mountains

dustbowl
10. 10. 2007
0 views

dustbowl

The Internet China
12. 10. 2007
0 views

The Internet China

shen 1
12. 10. 2007
0 views

shen 1

Triumph of Bolshevism
12. 10. 2007
0 views

Triumph of Bolshevism

Kukovecz
15. 10. 2007
0 views

Kukovecz

09 Panama s ppt
22. 10. 2007
0 views

09 Panama s ppt

Common By Product Feeds
04. 10. 2007
0 views

Common By Product Feeds

Dissertation Writing comms ug
27. 11. 2007
0 views

Dissertation Writing comms ug

TT
27. 11. 2007
0 views

TT

black holes v2
28. 11. 2007
0 views

black holes v2

Production of Calla Lily
07. 12. 2007
0 views

Production of Calla Lily

Water Track 8 7 15 051
07. 11. 2007
0 views

Water Track 8 7 15 051

PVC Toronto talk
16. 11. 2007
0 views

PVC Toronto talk

2022lecture2
19. 11. 2007
0 views

2022lecture2

Robertson
03. 10. 2007
0 views

Robertson

20050922 Crafoord Symposium
29. 08. 2007
0 views

20050922 Crafoord Symposium

field mmr naga
31. 12. 2007
0 views

field mmr naga

Anthony Kelly International
02. 01. 2008
0 views

Anthony Kelly International

fy2004 mfc construction
04. 01. 2008
0 views

fy2004 mfc construction

NASC PresentHanson
08. 08. 2007
0 views

NASC PresentHanson

Nicosia Raymond Pawson
08. 08. 2007
0 views

Nicosia Raymond Pawson

Methamphetamine final10 05
08. 08. 2007
0 views

Methamphetamine final10 05

ppt43
16. 10. 2007
0 views

ppt43

McCarthy Mitchell
29. 08. 2007
0 views

McCarthy Mitchell

Update FutureDirection LRago
22. 10. 2007
0 views

Update FutureDirection LRago

gef 160306
23. 10. 2007
0 views

gef 160306

IT Trends 2005 2010
14. 11. 2007
0 views

IT Trends 2005 2010

rec pond mgnt compressed
07. 01. 2008
0 views

rec pond mgnt compressed

Sci Case II
29. 08. 2007
0 views

Sci Case II

markenklima index q1 2005
05. 01. 2008
0 views

markenklima index q1 2005

yalenov2006
29. 08. 2007
0 views

yalenov2006

media 4917
08. 08. 2007
0 views

media 4917

gatorsncrocs
12. 10. 2007
0 views

gatorsncrocs

Eradicating Systemic Poverty
29. 11. 2007
0 views

Eradicating Systemic Poverty

Kennedy obesity 0904
08. 08. 2007
0 views

Kennedy obesity 0904

jsimon santacruz
29. 08. 2007
0 views

jsimon santacruz

9 0568 rusack r
20. 11. 2007
0 views

9 0568 rusack r

soc100ch10Corepwrpt
19. 02. 2008
0 views

soc100ch10Corepwrpt

Edward Albee
24. 02. 2008
0 views

Edward Albee

AFCEA NOVA Breakfast7Sept07v1
06. 03. 2008
0 views

AFCEA NOVA Breakfast7Sept07v1

Lakeside2
26. 03. 2008
0 views

Lakeside2

sHansen
29. 08. 2007
0 views

sHansen

Tectonics Terrestrial Planets2
07. 04. 2008
0 views

Tectonics Terrestrial Planets2

Sept SECC
02. 11. 2007
0 views

Sept SECC

Hercules
28. 03. 2008
0 views

Hercules

deprez presentation 12 1 05
30. 03. 2008
0 views

deprez presentation 12 1 05

HARIPARSAD Ishwarie 2
09. 04. 2008
0 views

HARIPARSAD Ishwarie 2

Beaulieu
10. 04. 2008
0 views

Beaulieu

sings2mw
29. 08. 2007
0 views

sings2mw

molgas twong
29. 08. 2007
0 views

molgas twong

newman1
14. 04. 2008
0 views

newman1

session 25 V2
17. 04. 2008
0 views

session 25 V2

Citel
22. 04. 2008
0 views

Citel

icra02
19. 06. 2007
0 views

icra02

ICHEP 04 Barr Higgs
19. 06. 2007
0 views

ICHEP 04 Barr Higgs

IBERs and e Theses
19. 06. 2007
0 views

IBERs and e Theses

HS P2P Liao
19. 06. 2007
0 views

HS P2P Liao

he b
19. 06. 2007
0 views

he b

HB2004
19. 06. 2007
0 views

HB2004

Hartenstein Oerebro03 pt1
19. 06. 2007
0 views

Hartenstein Oerebro03 pt1

Grid InteropSupport
19. 06. 2007
0 views

Grid InteropSupport

Grid Interop
19. 06. 2007
0 views

Grid Interop

grid 06talk
19. 06. 2007
0 views

grid 06talk

wednesday
29. 08. 2007
0 views

wednesday

comer5e ch08 HO
15. 11. 2007
0 views

comer5e ch08 HO

SAG YinG 9 Jan New
03. 01. 2008
0 views

SAG YinG 9 Jan New

02 Cattle2
26. 11. 2007
0 views

02 Cattle2

Grid Shib uk april05
19. 06. 2007
0 views

Grid Shib uk april05

20061130 woodling
30. 12. 2007
0 views

20061130 woodling

ch02exoh
07. 01. 2008
0 views

ch02exoh

Choose your way carefully
03. 10. 2007
0 views

Choose your way carefully

4 vista
16. 06. 2007
0 views

4 vista

33233 11162218 S
16. 06. 2007
0 views

33233 11162218 S

23
16. 06. 2007
0 views

23

2007 tips tricks
16. 06. 2007
0 views

2007 tips tricks

19b
16. 06. 2007
0 views

19b

EPL Membership
16. 06. 2007
0 views

EPL Membership

Entire Gra duation Slideshow
16. 06. 2007
0 views

Entire Gra duation Slideshow

elley web graphics
16. 06. 2007
0 views

elley web graphics

A Loose Confederation
14. 12. 2007
0 views

A Loose Confederation

employee 2004
16. 06. 2007
0 views

employee 2004

Obesity 1
08. 08. 2007
0 views

Obesity 1

Active Kill Disk
19. 06. 2007
0 views

Active Kill Disk

teall cost 3 ch16
24. 02. 2008
0 views

teall cost 3 ch16

CFA05
29. 08. 2007
0 views

CFA05

gemini sab
29. 08. 2007
0 views

gemini sab

NINDS Audience Report
08. 08. 2007
0 views

NINDS Audience Report

mm1
29. 08. 2007
0 views

mm1

ENGD POWERPOINT
16. 06. 2007
0 views

ENGD POWERPOINT

I3C BSML July2002
19. 06. 2007
0 views

I3C BSML July2002

igt 3
04. 03. 2008
0 views

igt 3

MassesofGalaxies
29. 08. 2007
0 views

MassesofGalaxies